Writing the Case for Support in Commissioner Language

A commissioner reading a bid does not want to know that participants felt better. They want to know what stops happening in their system because participants felt better — fewer GP contacts, fewer emergency admissions, fewer repeat referrals. Social prescribing services and connection programmes that have secured recurring funding have, by and large, learned to write two different documents: one for participants and staff, framed around wellbeing and connection, and one for commissioners, framed around risk and service use. The training gap is that most link workers and programme staff are only ever taught to write the first one.

The wellbeing-score trap

This is the failure mode worth naming: a programme collects pre- and post-intervention loneliness or wellbeing scores, sees a genuine improvement, and puts that improvement at the top of the funding renewal. It reads well internally. It does almost nothing for a commissioner who is weighing this bid against a diabetes prevention service with a cost-per-QALY attached.

The systematic review evidence on social prescribing and loneliness is instructive here, precisely because it is mixed. A 2021 systematic review in Perspectives in Public Health found that all nine included studies reported positive individual impacts on loneliness, but only three reported any reduction in service use — GP contact, emergency attendance, social worker involvement, or inpatient stays. A separate 2021 systematic review in the International Journal of Environmental Research and Public Health found consistent gains in self-esteem and self-confidence, but noted the trial evidence remained limited and the programmes studied too heterogeneous to generalise across. A 2022 qualitative meta-synthesis in BMC Health Services Research found that participants themselves describe the benefit as extending beyond social contact to restored meaningful participation — structured, purposeful activity, not contact for its own account.

None of that is a case for support in commissioner terms. It is a case for support in evaluator terms. Training that stops at “here is what the evidence shows” leaves staff able to describe the intervention but not to argue for it.

What commissioners are actually funding

Commissioners fund reductions in demand on services they are accountable for, or population-level risk they are required to report against. That means the translation work has three moves, in order.

1. Start with the risk category, not the intervention. The American Heart Association’s 2022 scientific statement gives a commissioner-legible number: social isolation and loneliness carry roughly a 30% increased risk of heart attack, stroke, or death from either. The 2023 U.S. Surgeon General’s advisory gives an even more portable comparator — mortality risk from social disconnection comparable to smoking up to fifteen cigarettes a day. These are the kind of figures that sit naturally next to a health board’s other risk-reduction targets. A bid that opens with cardiovascular or mortality risk is answering the question a commissioner is actually asking: why should this compete with a smoking cessation service for the same pound.

2. Name the service-use pathway explicitly, and be honest about its strength. The 2021 Perspectives in Public Health review found reduced service use in three of nine studies — not all nine. Overstating this is the fastest way to lose credibility with a commissioning team that has seen inflated claims before. State the pathway (“reduced isolation is associated with reduced GP and emergency contact in some but not all studies”) and be specific about the size of that “some.”

3. Anchor to a strategy document the commissioner already reports against. The UK’s 2018 loneliness strategy embedded loneliness measurement into the Office for National Statistics and funded social prescribing directly — a bid that ties local delivery to that existing infrastructure is asking the commissioner to fulfil a commitment already made, not to adopt a new one. The National Academies’ 2020 consensus report calling on health systems to routinely assess isolation in older adults, and the 2020 clinical commentary on that report discussing what routine assessment would require in practice, both give NHS and social care commissioners language they already use internally for screening and referral pathways.

Evidence status, stated plainly

Claim	Evidence status
Social prescribing improves self-reported loneliness or wellbeing	Consistently reported across qualitative and mixed-methods studies
Social prescribing reduces GP, A&E, or inpatient service use	Reported in a minority of studies reviewed; not consistent enough to promise
Loneliness and isolation raise cardiovascular and mortality risk	Strong, from large meta-analyses and a formal scientific statement
Structured, purposeful group activity outperforms unstructured social contact	Supported by qualitative synthesis; not yet tested in controlled comparison
Social prescribing is cost-effective at scale	Not established; the evidence gap is explicit in the underlying reviews

What this means in practice: write the risk case first, using figures that sit next to a commissioner’s other funded priorities — cardiovascular risk, mortality comparators, workforce absence costs like the Cigna finding that lonely workers miss work roughly twice as often through illness. Write the service-use case second, and scope it to what the evidence actually shows: possible, not guaranteed, reduction in downstream contact. Do not let the wellbeing data carry the argument on its own; it is the weakest lever in the room, however true it is.

Training staff to hold two registers at once

The programmes that do this well are not necessarily better at delivery. They are better at having someone on staff — often not the delivery lead — who can hold the participant-facing account and the commissioner-facing account separately, and translate between them without collapsing one into the other. That is a specific, teachable skill: read a scientific statement or a systematic review, extract the number that maps onto the commissioner’s own reporting framework, and drop the rest. It is closer to briefing a select committee than writing an impact report, and most link worker training does not touch it at all.

The National Academies’ commentary on routine isolation assessment is a useful training text precisely because it was written for clinicians deciding whether to act, not for advocates trying to persuade them. Reading it alongside a typical funding bid shows the gap: one asks “is this true and actionable,” the other usually asks “will this help me.”

What this does not solve

Better commissioner language does not fix a weak evidence base — it just states that base honestly instead of dressing it up. The service-use evidence for social prescribing remains genuinely thin, and the AHA’s 2022 statement is explicit that the absence of intervention trial evidence is the central research gap in this field, not a footnote to it. Nor does this address reach: a bid written in commissioner language secures funding for a programme, but it says nothing about whether that programme is reaching people who are isolated and unconnected to services, as opposed to people already engaged enough to be referred into one. Writing well for commissioners is a precondition for continued funding. It is not a substitute for asking who the programme is actually finding.